Regeneron Pharmaceuticals Inc - Company & Market Research Reports

Home /
Companies /
Regeneron Pharmaceuticals Inc

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

REFINE BY

KEYWORD

CATEGORIES

Drug Discovery 85
Oncology Drugs 84
Optical 76
Optical Disorders Drugs 75
Immune Disorders Drugs 72
Cardiovascular Drugs 51
Musculoskeletal Disorders Drugs 39
Dermatological Drugs 38
Biopharmaceuticals 36
Biotechnology 31
Genomics 29
Clinical Trials 29
Endocrine and Metabolic Disorders Drugs 27
Pharmaceuticals 23
Skin Cancer Drugs 21
Central Nervous System Drugs 19
Infectious Diseases Drugs 17
Respiratory Drugs 17
Allergy and Immunology 16
Infusions and Injectables 14
Gastrointestinal Drugs 14
Allergy Drugs 14
Drugs by Therapeutic Area 13
Lung Cancer Drugs 11
Dermatology 10
Hematological Drugs 10
Oncology 10
Leukemia Drugs 9
Needles and Syringes 8
Asthma Drugs 8
Pharmaceutical Manufacturing 8
Analgesics 7
Diagnostics 7
Biosimilars and Biosuperiors 7
Enzymes 6
Vaccines 6
Prostate Cancer Drugs 5
Lymphoma Drugs 5
Ovarian Cancer Drugs 5
Transdermal and Transmucosal Drug Delivery 5
Liver and Kidney Disorders Drugs 5
Company Reports 4
Therapeutic Area 4
Pulmonary Medicine 4
Cardiovascular Devices 4
Drug Delivery 4
Gastroenterology 4
Pharmaceutical Intermediates 3
Diabetes Drugs 3
Colon Cancer Drugs 3
Proteomics 3
Laboratory Equipment 3
Pediatrics 3
Sexual and Reproductive Health Drugs 3
Immunosuppressive Drugs 3
Liver Cancer Drugs 2
Healthcare Services 2
Pharmacoeconomics 2
Cervical Cancer Drugs 2
Brain Cancer Drugs 2
Cough and Cold Drugs 2
Medical Devices 2
Mental Disorders Drugs 2
Pancreatic Cancer Drugs 2
Kidney Cancer Drugs 2
Anti-Obesity Drugs 2
Cardiology 2
Endocrinology 2
Neurology 1
Hepatology 1
Generic Drugs 1
Fertility Services 1
Bladder Cancer Drugs 1
In Vitro Diagnostics 1
Infectious Disease Testing 1
Laboratory Testing 1
Animal Healthcare/Veterinary 1
Inhalers and Nebulisers 1
Stem Cells 1
Blood Banking 1
Biomarkers 1
Hematology 1
Nursing 1
Surgical Devices 1
Over the Counter (OTC) Drugs 1
Endoscopy 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Nanomedicine 1
Alzheimer's Disease Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



273 reviews

701 Results (Page 28 of 36)
- Relevance
  Sort by

Retinal Vein Occlusion Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3941EUR$4,490USD£3,382GBP

Proliferative Diabetic Retinopathy (PDR) Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3941EUR$4,490USD£3,382GBP

Diabetic Retinopathy Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3941EUR$4,490USD£3,382GBP

Retinal Disorder Treatment Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3941EUR$4,490USD£3,382GBP

Age-Related Macular Degeneration Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3941EUR$4,490USD£3,382GBP

NEED HELP FINDING THE RIGHT PRODUCT? Becky will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

CAR-T Cell Therapies: Intellectual Property Landscape (Featuring Historical and Contemporary Patent Filing Trends, Prior Art Search Expressions, Patent Valuation Analysis, Patentability, Freedom to Operate, Pockets of Innovation, Existing White Spaces, and Claims Analysis)

 Report
April 2022
116 Pages
Global

From

€1140EUR$1,299USD£978GBP

Retinal Vein Occlusion Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

 Report
March 2025
180 Pages
Global

From

€3358EUR$3,825USD£2,881GBP

€3950EUR$4,500USD£3,390GBP

Hypercholesterolemia Treatment Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F

 Report
April 2025
186 Pages
Global

From

€3358EUR$3,825USD£2,881GBP

€3950EUR$4,500USD£3,390GBP

DME Therapies Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

 Report
February 2024
96 Pages
Global

From

€3500EUR$4,271USD£3,108GBP

Ophthalmic Therapeutic Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
February 2024
93 Pages
Global

From

€3500EUR$4,271USD£3,108GBP

Listeria Monocytogenes Infections Treatment Global Market Report 2024

 Report
February 2024
175 Pages
Global

From

€4389EUR$5,000USD£3,766GBP

Drug Discovery Services Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3941EUR$4,490USD£3,382GBP

Fibrodysplasia Ossificans Progressive - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1097EUR$1,250USD£942GBP

Persistent Facial Erythema Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
September 2024
89 Pages
Global

From

€3500EUR$4,271USD£3,108GBP

Retinal Disorder Treatment Market Size, Share & Trends Analysis Report By Type (Macular Degeneration, Diabetic Retinopathy), By Dosage Form, By Distribution Channel, By Product Type, And Segment Forecasts, 2023 - 2030

 Report
February 2023
100 Pages
Global

From

€5223EUR$5,950USD£4,482GBP

Aplastic Anemia- Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1097EUR$1,250USD£942GBP

REGN4461 Market Size, Forecast, and Emerging Insight - 2032

 Report
February 2024
30 Pages
Global

From

€2853EUR$3,250USD£2,448GBP

Engineering Microorganisms into Powerful Micromachines: Can Synthetic Biology Foster Bio-Revolution?

 Report
October 2021
72 Pages
Global

From

€1312EUR$1,495USD£1,126GBP

Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) - Market Insights, Epidemiology, and Market Forecast - 2032

 Report
January 2024
175 Pages
Global

From

€8339EUR$9,500USD£7,156GBP

Myostatin Inhibitor - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1097EUR$1,250USD£942GBP

701 Results (Page 28 of 36)
- 1
- 26
- 27
- 28
- 29
- 30

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.